
Center Overview
One of the major goals of the Stanford University Medical Center is to translate research and clinical insights into
practical advances that enhance and prolong life, reflecting the promise “from bench to bedside and back again.”
The Stanford Medical Center is well known for its breakthrough technologies and treatments, including the first synthesis of
biologically active DNA in a test tube, the first construction of a recombinant DNA molecule containing DNA from two
different species, discovery of immune response genes, and development of the microarray technology that allows researchers
to see at once which genes of the thousands present in a cell are switched “on.”
The Stanford Medical Center is on the northern end of the Stanford University campus, Palo Alto, California. The Medical
Center includes the Stanford Hospital & Clinics, the Lucile Packard Children’s Hospital and the Stanford School of Medicine.
The close physical and working relationship among these entities enhances their mutual commitment and ability to provide
state-of-the-art patient care.
Stanford Hospital & Clinics
As the primary teaching hospital for the School of Medicine, Stanford Hospital & Clinics has pioneered medical advances,
including the first successful adult human heart transplant in the country and the first combined heart/lung transplant in
the world. Stanford Hospital & Clinics is known worldwide for the advanced patient care provided by our staff, particularly
for the treatment of rare, complex disorders in areas such as cancer treatment, cardiac care, neurology, neurosurgery and
organ transplants. In recognition of our excellent care, our hospital and physicians consistently rank among the top in the
nation in surveys by consumers and health care professionals. Stanford was named to the 2004 Honor Roll of America’s
Best Hospitals by U.S.News & World Report, a handful of hospitals that excel not in one or two specialties, but in six
or more.
Stanford Hospital & Clinics has 594 licensed beds and 33 operating rooms. In 2002, it had a medical staff of 1,846, a house
staff of interns and residents of 617, and a nursing staff of 1,363 RNs and 282 LVNs and nursing assistants. There were
20,426 admissions, 38,323 emergency patient visits and 471,728 clinic outpatient visits. Other facilities include an
outpatient psychiatry facility, a "Life Flight" helicopter and landing facility on the hospital’s roof that is used to
transport critically injured patients from up to 150 miles away and the Health Library, a free community service http://med.stanford.edu/healthlibrary/. Visit www.stanfordhospital.com for more information.
Lucile Packard Children’s Hospital
Lucile Packard Children’s Hospital (LPCH) at Stanford is an internationally recognized hospital devoted entirely to the care
of children and expectant mothers. Providing general acute and tertiary pediatric medical and surgical services associated
with Stanford University Medical Center, LPCH offers patients a full range of health care programs and services, from
preventive and routine care to the diagnosis and treatment of serious illness and injury. In 2004 US News and World Report named Lucile Packard Children’s Hospital as one of the best pediatric hospitals in America.
The hospital’s relationship to Stanford University and its Silicon Valley location give LPCH the ability to leverage
leading-edge technology to improve every aspect of patient care. From the development of new vaccines and devices for
cardiac intervention to breakthroughs in gene therapy, research leaders at LPCH are improving the future of medicine every
day.
In 2002 LPCH had 248 licensed beds, a medical staff of 862, more than 1,900 employees, 12, 308 patient discharges and 92,260
clinic visits. LPCH also has extensive outreach services, including the Health Van, which provides pediatric primary care to
uninsured children; the Mommy Van, which provides pregnancy care; and the Adolescent Van, which provides health care to
homeless and high-risk teens. Visit www.lpch.org for more information.
Stanford University School of Medicine
Stanford University School of Medicine is a premier research-intensive medical school that improves health through leadership
and collaborative discoveries, and innovation in patient care, education and research. The oldest medical school in the
western United States, it was established in 1858 as the medical department of the University of the Pacific. In 1908, the
school was adopted as Stanford’s School of Medicine and, in 1959, it moved to the Stanford campus. In 2002 the school had
733 faculty members 465 M.D. students. The school provides an education environment that encourages intellectual diversity
in students interested in developing a scholarly, investigative approach to problems in medicine and science. In 2002 faculty
members received grants and contracts totaling more than $272 million in support of research, teaching and patient care.
Among the interdisciplinary programs and facilities engaged in the two-way transfer of ideas between laboratories and
patient-care settings are:
Beckman Center for Molecular and Genetic Medicine
Department of Bioengineering
Stanford Program for Biomedicine and Biosciences
General Clinical Research Center
Howard Hughes Unit in Molecular and Genetic Medicine
Lucas Center for Magnetic Resonance Spectroscopy and Imaging
Program in Molecular and Genetic Medicine
Stanford Institute for Cancer/Stem Cell Biology and Medicine
Please visit http://med.stanford.edu/

Clinical Research Experience
Stanford University Medical Center has been active in clinical research for more than 40 years, including Phase I, II, III,
and IV drug studies and device studies. Clinical research is a cornerstone of the teaching hospital, with hundreds of
clinical studies currently underway with 400 faculty investigators.
Clinicians closely involved in patient care work alongside scientists pursuing basic research questions to trigger fruitful
and innovative collaborations. Being an integral part of the University campus generates joint, unique research programs
between School of Medicine faculty and other Stanford researchers in engineering, physics, biology, chemistry, statistics,
psychology, and computer science. Please see Program for Bioengineering,
Biomedicine and Biosciences at Stanford.
Potential sponsors of biotechnology, pharmaceutical and medical device research are invited to contact SPCTRM, the clinical trials office at Stanford,
for more information.
Therapeutic Areas

Facility Description
The Stanford University Medical Center encompasses 1.75 million gross square feet available for clinical care, and another 1.2 million gsf are used for teaching and research. Combined, these core medical center facilities occupy approximately 110 acres of University campus lands. In addition to their significant facilities on the Stanford campus, both the School of Medicine and the Medical Center maintain important academic and clinical relationships with off-site affiliates. A primary relationship with the Veterans Affairs Palo Alto Health Care System supports Stanford and VA-based faculty through joint appointments and collaborative research programs. The research program at the Palo Alto VA hospital is the largest in the Veterans Affairs system.

Investigator Experience
Stanford ranks highest of all U.S. medical schools in research expenditures per faculty member, attesting to Stanford's highly competitive medical research (1994-95 Institutional Profile by the Association of American Medical Colleges). Faculty members of the Stanford University School of Medicine, numbering 933, received grants and contracts in 1997 totaling more than $158 million in support of research, teaching and patient care.
The Stanford University Faculty Research Directory
contains names of medical investigators and descriptions of their areas of expertise and publications. You can search this database by therapeutic area (e.g. diabetes, cardiovascular) or by investigator name.

Staff Expertise
SPCTRM clinical trials office at Stanford University School of Medicine
is a central resource meeting sponsor needs for information about
clinical research at Stanford, communication with faculty, and
facilitation of the clinical research process. Contact SPCTRM to identify principal investigators for
adult and pediatric clinical studies and to obtain information about
Stanford clinical research activities, facilities and research
capabilities. The Instituational Review Board (IRB) meets 3 times a
month to review human subjects protocols. Working with sponsors,
contract administrators, investigators and their research staffs,
SPCTRM provides communication, continuity, and administration
throughout the clinical research process.
SPCTRM operates a clinical trials center at Stanford University
Medical Center to facilitate faculty investigators involved in
industry-sponsored studies, and provides ongoing clinical research
education for Stanford clinical personnel.
Sponsors of biotechnology, pharmaceutical and medical device research
are invited to contact SPCTRM for additional information.

Patient Demographics
Stanford University Medical Center serves a patient base of over 4 million people. Outpatient visits totaled 647,963 and inpatient admissions 36,267 (in Fiscal Year 1999).

Other Information
For visitors: maps and
visitor info.
STANFORD CLINICAL TRIALS DIRECTORY

Currently Enrolling Trials
CenterWatch is listing the following trials that are actively recruiting patients at this center.
- A Double-Blind, Randomized, Multicenter Pilot Study to Evaluate the Efficacy and Safety of Etanercept 50mg SC Twice Weekly in the Treatment of Moderate to Severe Lichen Planus
- A multicenter, randomized, blinded, controlled, parallel group trial to demonstrate the efficacy of Reeg guided pharmacotherapy of patients with treatment-resistant depression
- A study at the onset of Type 1 Diabetes to preserve insulin secretion.
- Are you currently on Estrogen Replacement Therapy and Unsure of what to do?
- Are you having problems sleeping through the night or staying awake during the day?
- Assessing Cognition: Interactive Voice Response System
- Cholesterol lowering agents to slow progression of Alzheimer's disease (CLASP study)
- Comparing Effects of Three Sources of Garlic on Blood Cholesterol Levels : The study will investigate whether fresh garlic compared with the effect of two, commonly used, commercially available garlic supplements can positively affect cholesterol levels in adults.
- Do you and a family member have DEPRESSION?
- Do you and a family member have DEPRESSION?
- Do you and a family member have DEPRESSION?
- Do you and a family member have DEPRESSION?
- Do you and a family member have DEPRESSION?
- Do you and a family member have DEPRESSION?
- Do you and a family member have DEPRESSION?
- Do you have Idiopathic Pulmonary Fibrosis?
- Do you have Type 2 Diabetes?
- Does someone in your family have Type 1 Diabetes?
- Does Your Child Suffer From Diaper Rash?
- Double-Blind, Phase II, 26-Day Study Evaluating The Efficacy of Mifepristone Versus Placebo in Treating Depression and Psychosis (HPA III Study).
- First Episode Psychosis Study (CAFÉ)
- Have you or a family member been diagnosed with a brain aneurysm? Is there also a family history of brain aneurysms?
- Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication
- Lidoderm 5% Topical Patch: A phase IV, open label, 3 month prospective randomized controlled, single center study in subjects with pain due to cervical facet arthropathy, "Whiplash" (eProtocol 5521)
- Male and female volunteers needed for skin study
- Randomized trial of Zocor (simvastatin) in patients with Pulmonary Hypertension
- Randomized, bypass surgery study for symptomatic stroke or mini stroke from one or both blocked carotid artery(ies).
- Randomized, Multicenter, Open Label, Phase IV Study Evaluating the Efficacy and Safety of 16-Week Versus 24-Week Treatment with PEGASYS in Combination with Copegus in Interferon-naïve Patients with Chronic Hepatitis C Genotype 2 or 3 Virus Infection
- Safety of a fifth dose of Diphtheria Tetanus Acellular Pertussis Vaccine (DTaP) in children who had an extensive local reaction after the fourth DTaP dose (Revaccination Study)
- Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
- Seroquel in Dysphoric Hypomania
- Stanford Studies Health Benefits of Alcohol.
- Stasis Dermatitis sufferers may be eligible for study
- Stress and Breast Cancer Study
- Study of self-conscious emotions in women living with breast cancer
- Study to evaluate whether a change in medication will lessen the sexual side effects caused by many antidepressants
- Surviving Childhood Sexual Abuse
- Surviving Childhood Sexual Abuse
- The purpose of this study is to determine whether memantine (Namenda), in doses up to 20 mg/day, will be effective in treating the obsessive-compulsive disorder (OCD) of adult patients who have not responded to their OCD medication.
- The study is looking at the metabolic side effects of the new antipsychotic medications. Participants should be stable on one of the following medications: olanzapine (zyprexa), ziprasidone (geodon), risperidone (risperdal) or aripiprazole (abilify). Patient's medications won't be changed. The study involves 3 visits at the Palo Alto VA and Stanford Hospital.
- Treatment of Schizoaffective Disorder Using Mifepristone
- UPBEAT Study: Understanding Pine Bark Extract as an Alternative Treatment

Contact Information
For more information, please contact:
Stanford University School of Medicine
SPCTRM Clinical Trials Office
555 Middlefield Road
Menlo Park, CA 94025 USA
Phone: 650-498-7425
Fax: 650-498-7564
E-mail:
If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the E-mail form below. A representative from the research center will then follow up with you.